Some detailed articles on specific MPN treatments are outlined below.

CYTOREDUCTION: Hydroxycarbamide (hydroxyurea) versus Interferon Alpha

Ropeginterferon  – a pegylated form of interferon alpha approved in Europe for PV but not yet available in Australia.

Ruxolitinib

Possible future treatments via targeted therapies – not yet available in Australia

Share to: